Inflammation ๋ชฉ์ฐจ

์กฑ๋ณด :: ๋ณ‘๋ฆฌํ•™์ด๋ž€? ์„ธํฌ, ์กฐ์ง, ๊ธฐ๊ด€์—์„œ ๋ณ‘์  ์ƒํƒœ๋ฅผ ๊ตฌ๋ถ„ํ•˜๊ณ , ๋ณ‘์  ์ƒํƒœ์— ๋Œ€ํ•œ ์„ธํฌ์™€ ์กฐ์ง์˜ ๋ฐ˜์‘๊ณผ ๊ธฐ์ „์„ ์—ฐ๊ตฌํ•˜๋Š” ํ•™๋ฌธ

Definition

  • ์—ผ์ฆ : ์™ธ๋ถ€์˜ ์ž๊ทน์— ๋Œ€ํ•œ ์กฐ์ง์˜ ๋ฐ˜์‘
  • dynamicํ•œ ๋ฐ˜์‘. ์ •์ฒด๋˜์–ด ์žˆ์ง€ ์•Š๋‹ค.
  • tissue์— ๋”ฐ๋ผ ์ƒ๋‹นํžˆ ์—ฌ๋Ÿฌ ํ˜•ํƒœ๋กœ ๊ด€์ฐฐ๋œ๋‹ค.
  • โ€œa process which begin following sublethal injury and end with complete healingโ€ ^[By Ebert, 1965] : ์น˜์‚ฌ์— ๊ฐ€๊นŒ์šด ๋ถ€์ƒ์—์„œ ์น˜์œ ๋กœ ๋๋‚˜๋Š” ๊ณผ์ •
  • โ€œexogenousํ•œ ์„ธ๊ท , ๋ฐ”์ด๋Ÿฌ์Šค, ๊ธฐ์ƒ์ถฉ, ๋…์†Œ์— ๋Œ€ํ•ญํ•˜๋Š” ์‹ ์ฒด์˜ active defense mechanismโ€
  • ํ”ผ๊ฐ€ ๋งŽ์ด ๋ชฐ๋ฆฌ๊ณ (swollen vessels), ๊ฐ์ข… ๊ณ ์ฒด์„ฑ๋ถ„(๋ฉด์—ญ์„ฑ๋ถ„; leukocytes)๊ณผ ์•ก์ฒด์„ฑ๋ถ„(ํ˜ˆ์žฅ์„ฑ๋ถ„; plasma)๋“ค์ด ๊ด€์—ฌํ•œ๋‹ค.
  • [hyperemia|hyperemic] change, leaky
  • ํ˜ˆ๊ด€์ด ํ™•์žฅ๋˜๊ณ , ํ˜ˆ์•ก์ด ์ •์ฒด๋˜๊ณ , ๋ฐฑํ˜ˆ๊ตฌ๋“ค์ด ๋ชฐ๋ ค์„œ(emigration) ๋‹ค๋ฅธ ๊ณณ์œผ๋กœ ์ด๋™(emigration)ํ•œ๋‹ค.

Cardinal signs

  • heat : ํ˜ˆ์•ก ํ๋ฆ„์˜ ์ฆ๊ฐ€๋กœ ์—ด์ด ๋‚จ
  • redness : ํ˜ˆ์•ก๋Ÿ‰์˜ ์ฆ๊ฐ€๋กœ ๋ถ‰๊ฒŒ ๋ณด์ž„
  • swelling : ํ˜ˆ์•ก์˜ ์ฆ๊ฐ€, ์‚ผ์ถœ๋ฌผ์ด ํ˜ˆ๊ด€์—์„œ ์ฃผ๋ณ€ ์กฐ์ง์œผ๋กœ ๋น ์ ธ๋‚˜์˜ด
  • pain : ์‹ ๊ฒฝ์˜ ์••๋ฐ•, ๋…์„ฑ ๋ฌผ์งˆ ๋“ฑ - ์•„ํ”ˆ ๋ถ€์œ„๋Š” ์“ฐ์ง€ ๋ง๋ผ๋Š” ์‹ ํ˜ธ๋ฅผ ์ฃผ๋Š” ๊ฒƒ
  • loss of function : ๊ธฐ๋Šฅ ์ƒ์‹ค (ํ˜ˆ๊ด€ ๋‚ด ์•ก์ฒด ์„ฑ๋ถ„๋“ค์ด ๋น ์ ธ๋‚˜๊ฐ€๊ณ , ์ „์ฒด์ ์ธ ํ˜ˆ์•ก ์–‘๋„ ๋งŽ์ด ์ฆ๊ฐ€ํ•œ๋‹ค)

์กฑ๋ณด :: ์—ผ์ฆ์˜ 5๋Œ€ ์ฃผ์š”๋ฐ˜์‘์€ heat, redness, swelling, pain, loss of function
๊ทธ ์ค‘ ๊ตญ์†Œ ๋ฐ˜์‘์€ redness, swelling, pain

  • ๋™๋งฅ๊ณผ ๋ชจ์„ธํ˜ˆ๊ด€์œผ๋กœ ํ˜ˆ์•ก์ด ๋งŽ์ด ๋ชฐ๋ฆฌ๊ฒŒ ๋˜๋ฉด ์ •์ˆ˜์••์ด ๋†’์•„์ง
  • ๋งŽ์€ ์–‘์˜ ์•ก์ฒด๊ฐ€ ์˜ค๋ฉด์„œ ๋†๋„๊ฐ€ ๋ฌฝ์–ด์ ธ ๊ต์งˆ์‚ผํˆฌ์••(colloid osmotic pressure)์ด ๋‚ฎ์•„์ง
  • ๋‚˜๊ฐ€๋Š” ์ •์ˆ˜์•• ์ฆ๊ฐ€, ๋“ค์–ด์˜ค๋Š” ์‚ผํˆฌ์•• ๊ฐ์†Œ โ†’ ํ˜ˆ์žฅ ์„ฑ๋ถ„๋“ค์ด ๋น ์ ธ๋‚˜๊ฐˆ ์ˆ˜ ์žˆ๋‹ค

Irritants causing inflammation

  • pathogenic organisms : ๊ท , ๋ฐ”์ด๋Ÿฌ์Šค, fungi, protozoa, parasitic metazoa ๋“ฑ์˜ ๋ฏธ์ƒ๋ฌผ๋“ค
  • chemical poisons : ์ˆ˜์—†์ด ๋‹ค์–‘ํ•จ. ์ˆ˜๋งŽ์€ chemical๋“ค์ด ์—ผ์ฆ ๋ฐ˜์‘์„ ์ผ์œผํ‚ฌ ์ˆ˜ ์žˆ์Œ
  • mechanical and thermal injuries : ์•„์ฃผ ๋œจ๊ฒ๊ฑฐ๋‚˜ ์•„์ฃผ ์ฐจ๊ฐ‘๊ฑฐ๋‚˜, light, radiant energy, electricity
  • immune reactions : Ab+Ag^[์—ฌ๋Ÿฌ ๊ฐœ์˜ ํ•ญ์ฒด๊ฐ€ ์—ฌ๋Ÿฌ ๊ฐœ์˜ ํ•ญ์›์„ ๋ถ™์žก์•„ ํฐ ๊ตฌ์กฐ๋ฌผ์ด ํ˜•์„ฑ๋˜๋ฉด ํ˜ˆ๊ด€์„ ๋ง‰๊ฒŒ ๋จ], hypersensitivity, serum sickness(ํ˜ˆ์ฒญ๋ณ‘)^[๋ฐฑ์‹ ์— ์žˆ๋Š” ํ˜ˆ์ฒญ์— ๋Œ€ํ•œ ๋ฉด์—ญ ๋ฐ˜์‘์ด ๊ณผ๋„ํ•˜๊ฒŒ ๋ฐœ์ƒ], autoimmune disease

์กฑ๋ณด :: ์—ผ์ฆ์„ ์ผ์œผํ‚ค๋Š” ์›์ธ์„ ๊ทธ๋ฃน๋ณ„๋กœ ๋‚˜๋ˆ„๊ณ , ์›์ธ๋“ค์„ ๋‚˜์—ดํ•˜์‹œ์˜ค.
๋ณ‘์›์ฒด(์„ธ๊ท ,๋ฐ”์ด๋Ÿฌ์Šค,..), ํ™”ํ•™์  ๋…์„ฑ๋ฌผ์งˆ, ๊ธฐ๊ณ„์ /์—ด ์†์ƒ(์—ด,์ „๊ธฐ,๋ฐฉ์‚ฌ์„ ,์ถ”์œ„), ๋ฉด์—ญ ๋ฐ˜์‘(ํ•ญ์›ํ•ญ์ฒด๋ฐ˜์‘, ๊ณผ๋ฏผ๋ฐ˜์‘, ํ˜ˆ์ฒญ๋ณ‘, ์ž๊ฐ€๋ฉด์—ญ์งˆํ™˜)

Four major components

์—ผ์ฆ์ด ์ƒ๊ฒจ์„œ ์ผ์–ด๋‚˜๋Š” ๋ณ€ํ™”

์กฑ๋ณด :: ์—ผ์ฆ์˜ 4๋Œ€ ์ฃผ์š” ์„ฑ๋ถ„ - plasma protein, fixed tissue cells, leukocytes & platelets, inflammatory mediators (+๊ฐ„๋‹จํ•œ ์„ค๋ช…๊นŒ์ง€!!)
- plasma protein์˜ ๊ตฌ์„ฑ ์„ฑ๋ถ„์€ albumin, immunoglobulin, zymogens
- fixed tissue cell์—๋Š” ๋น„๋งŒ์„ธํฌ(mast cell), ์„ฌ์œ ์•„์„ธํฌ(fibroblast), ํ˜ˆ๊ด€๋‚ดํ”ผ์„ธํฌ(endothelium) ๋“ฑ

  1. Plasma proteins : ๋‹จ๋ฐฑ์งˆ์ด ๋งŽ์€ ํ˜ˆ์žฅ ์„ฑ๋ถ„๋“ค์˜ ๋ณ€ํ™”
    • ์ฃผ์š” ์„ฑ๋ถ„ : albumin, immunoglobulin
    • various proteins : zymogen, fibrolytic, coagulation, kinin system ๋“ฑ
  2. Fixed tissue cells
    • ์–ธ์ œ ์ ๊ตฐ์ด ๋‚˜ํƒ€๋‚ ์ง€ ๋ชฐ๋ผ ๋Œ€๊ธฐํ•˜๊ณ  ์žˆ๋Š” ์„ธํฌ๋“ค. ์ด fixed cells์—์„œ ๋ฐ˜์‘์ด ์ผ์–ด๋‚จ.
    • ํ‘œํ˜„ํ˜•์ด ๋ณ€ํ™”๋˜๊ฑฐ๋‚˜ ์—ผ์ฆ ๋งค๊ฐœ์ฒด๋ฅผ ์ƒ์‚ฐํ•˜์—ฌ ์—ผ์ฆ์ด ์ƒ๊ฒผ๋‹ค๋Š” ๊ฒƒ์„ ์•Œ๋ฆผ
    • cytokines(์—ฐ๋ฝํ•˜๋Š” ๋ฌผ์งˆ๋“ค)
    • mast cell์€ ์—ผ์ฆ ๋งค๊ฐœ์ธ์ž(๋Œ€ํ‘œ์ ์œผ๋กœ ํžˆ์Šคํƒ€๋ฏผ)๋ฅผ ๊ฐ€์ง„๋‹ค. ์—ผ์ฆ์ด ์ƒ๊ธฐ๋ฉด ๋ฐ”๋กœ ๋ฐ˜์‘ํ•  ์ˆ˜ ์žˆ๋„๋ก ๋ฏธ๋ฆฌ ๋งŒ๋“ค์–ด๋‘ฌ์•ผ ํ•˜๋Š”๋ฐ, ์œ„ํ—˜ํ•œ ๋ฌผ์งˆ์ด๊ธฐ ๋•Œ๋ฌธ์— ํŠน์ • ์„ธํฌ๋“ค๋งŒ ๊ฐ€์ง€๊ณ  ์žˆ๋‹ค.
  3. Leukocytes and platelets
    • leukocyte๋Š” ํ˜ˆ๊ด€ ๋ฐ–์œผ๋กœ(perivascular space) ๋‚˜๊ฐ€์„œ ์—ผ์ฆ ์›์ธ๋ฌผ์งˆ์„ phagocytosis
    • platelet์€ immune mediator(๋‹ค ์‹ธ์šฐ๊ณ  ๋‚˜๋ฉด ์ด์ œ ์ •๋ฆฌํ•˜๊ณ  ๋‹ค์‹œ ์›๋ž˜๋Œ€๋กœ ๋Œ์•„์™€์•ผ ํ•จ. ๊ทธ๋Ÿฐ ๊ณผ์ •์„ ๋งค๊ฐœํ•จ)
  4. Inflammatory mediators
    • proteins, acidic lipids, vasoactive amines

mediators

  • preformed mediators in granulocytes^[์ด๋ฏธ ๋งŒ๋“ค์–ด์ ธ ์žˆ์ง€๋งŒ, ๋‹น์žฅ ํ•„์š”ํ•œ ๊ฑด ์•„๋‹ˆ๋‹ˆ ์•ˆ์ „ํ•˜๊ฒŒ ๋ณด๊ด€ํ•˜์ž!] : histamines, serotonin, lysosomal enzymes
  • newly synthesized^[์—ผ์ฆ์ด ์ƒ๊ฒผ์„ ๋•Œ ์ƒˆ๋กœ ํ•ฉ์„ฑ] : prostaglandins, leukotrienes, platelet-activating factors, activated oxygen species, nitric oxide, cytokines, defensins
  • plasma proteins^[๋‹ค๋ฅธ ๊ธฐ๊ด€์—์„œ ์ด๋ฏธ ๋งŒ๋“ค์–ด์กŒ์ง€๋งŒ, ๋น„ํ™œ์„ฑ ์ƒํƒœ๋กœ ๋Œ์•„๋‹ค๋‹˜]
    • complement(์—ผ์ฆ์ด ์ƒ๊ธฐ๋ฉด cascade์— ์˜ํ•ด ์—ผ์ฆ ์œ ๋ฐœ ๋ฌผ์งˆ๋กœ ๋ณ€ํ™”) : C3a, C5a, C3b, C5b-9 ๋“ฑ

์ด๋Ÿฐ 4๊ฐ€์ง€ ๋ฌผ์งˆ๋“ค์ด ์ •์ƒ๋ณด๋‹ค ๋งŽ์•„์ง€๊ฑฐ๋‚˜ ์ค„์–ด๋“œ๋Š” ๋ณ€ํ™”๊ฐ€ ๋‚˜ํƒ€๋‚จ.

์กฑ๋ณด :: Newly synthesized inflammatory mediator 3๊ฐœ ์ด์ƒ
prostaglandin(โ†๋ชจ๋“  ๋ฐฑํ˜ˆ๊ตฌ, ํ˜ˆ์†ŒํŒ, EC) / leukotrine(โ†๋ชจ๋“  ๋ฐฑํ˜ˆ๊ตฌ) / Platelet-activating factor(โ†๋ชจ๋“  ๋ฐฑํ˜ˆ๊ตฌ, EC) / Cytokine(โ†๋ฆผํ”„๊ตฌ, ๋Œ€์‹์„ธํฌ, EC)

์กฑ๋ณด :: preformed mediators ์ข…๋ฅ˜, ๊ธฐ๋Šฅ, ๋ถ„๋น„ํ•˜๋Š” ์„ธํฌ
histamine (ํ˜ˆ๊ด€ ํˆฌ๊ณผ์„ฑ ์ฆ๊ฐ€ โ†๋น„๋งŒ์„ธํฌ,ํ˜ธ์—ผ๊ตฌ,ํ˜ˆ์†ŒํŒ) / serotonin (ํ˜ˆ๊ด€ ํˆฌ๊ณผ์„ฑ ์ฆ๊ฐ€ โ†ํ˜ˆ์†ŒํŒ) / lysosomal enzyme (์‹์„ธํฌ ์ž‘์šฉ ๋„์›€ โ†ํ˜ธ์ค‘๊ตฌ, ๋Œ€์‹์„ธํฌ)
+) bradykinin(โ†ํ˜ˆ๊ด€๋‚ดํ”ผ์„ธํฌ, ๋ฐฑํ˜ˆ๊ตฌ) / substance P(โ†๋น„๋งŒ์„ธํฌ, ํ˜ธ์—ผ๊ตฌ, C-reactive ์‹ ๊ฒฝ์„ฌ์œ )

  • ์‚ผ์ถœ๋ฌผ์˜ ๋ฐœ์ƒ
  • ํžˆ์Šคํƒ€๋ฏผ์— ์˜ํ•ด ๋ชจ์„ธํ˜ˆ๊ด€ ์ˆ˜์ถ•์ด ์ผ์–ด๋‚˜๋ฉด ํ˜ˆ๊ด€ ์‚ฌ์ด์— ๊ฐ„๊ทน์ด ์ƒ๊ฒจ ๊ทธ ์‚ฌ์ด๋กœ ํ˜ˆ์žฅ ์„ฑ๋ถ„์ด๋‚˜ ๋ฐฑํ˜ˆ๊ตฌ๊ฐ€ ๋น ์ ธ๋‚˜๊ฐˆ ์ˆ˜ ์žˆ๊ฒŒ ๋œ๋‹ค. ๊ทธ ๋ถ€์œ„์—์„œ exudate(์‚ผ์ถœ๋ฌผ), ์ง„๋ฌผ์ด ์ƒ๊ธด๋‹ค. fibrinogen ๋“ฑ์ด ์™€์„œ ์—ผ์ฆ์ด ๋” ๋ฒˆ์ง€๋Š” ๊ฒƒ์„ ๋ง‰๋Š”๋‹ค.

๋‹ค์Œ ๋‹จ์› : ๋ณ‘๋ฆฌ1(B) - 3.2 ์—ผ์ฆ์˜ Classification